Collaboration with NVIDIA Inception represents a significant milestone in Aisthesis Medical’s mission to transform acute care with artificial intelligence.
We are pleased to announce that Aisthesis Medical has been accepted into the NVIDIA Inception Programme, a prestigious global initiative that supports high-potential startups harnessing the power of AI to drive innovation.
NVIDIA Inception offers a unique framework to help startups scale faster through access to cutting-edge technology, technical expertise, and a global network of partners and collaborators. This collaboration represents a significant milestone in Aisthesis Medical’s mission to transform acute care with artificial intelligence.
As part of the programme, Aisthesis Medical will benefit from:
- Access to NVIDIA’s advanced GPU infrastructure, enabling rapid development and optimisation of our AI models
- Technical resources and training, helping our engineering team refine and scale our predictive analytics
- Increased visibility and collaboration opportunities within the AI and healthcare innovation ecosystem
These resources will directly support the ongoing development of VIOSync, our AI-powered clinical decision support platform for early sepsis prediction and intervention. With VIOSync, we aim to deliver real-time, multimodal insights that improve clinical workflows, reduce time-to-treatment, and help combat antimicrobial resistance through more precise and timely use of antibiotics.
Joining NVIDIA Inception aligns with our broader goal to accelerate the safe and effective adoption of AI in healthcare, and we look forward to collaborating with the NVIDIA community to bring impactful, data-driven solutions to clinicians and patients worldwide.
About Aisthesis Medical
Aisthesis Medical is a deep-tech medtech startup developing cutting-edge AI-driven solutions to revolutionize acute care. Founded in 2022, our mission is to save lives by predicting and preventing sepsis before it becomes fatal. Aisthesis Medical is revolutionizing acute care with VIOSync, the first holistic AI-driven sepsis care platform that goes beyond early prediction to guide clinical intervention and optimize patient outcomes. VIOSync, predicts sepsis up to 48 hours earlier, integrates directly into hospital workflows, and optimizes treatment pathways to reduce unnecessary antibiotic use.